Novel Levodopa Formulations for Parkinson's Disease.

about

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease.Motor Complications of Dopaminergic Medications in Parkinson's Disease.

P2860

Q46354756-B84261A9-3D61-4EED-A22C-F05965C298EC Q47754459-5E62A892-620A-4CED-B8A6-09E363A61F3E Q55279095-2EF1FE0E-BDB0-4FC3-9EED-0EFBC3CDFBDE

P2860

Novel Levodopa Formulations for Parkinson's Disease.

Item

http://www.wikidata.org/entity/Q38981419

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Novel Levodopa Formulations for Parkinson's Disease.

@en

type

Item

label

Novel Levodopa Formulations for Parkinson's Disease.

@en

prefLabel

Novel Levodopa Formulations for Parkinson's Disease.

@en

P1476

Novel Levodopa Formulations for Parkinson's Disease.

@en

P2093

Maria Eliza Freitas

http://www.w3.org/2001/XMLSchema#string

Marta Ruiz-Lopez

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

A brief history of levodopa.

Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.

Pathophysiology of motor fluctuations in Parkinson's disease.

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results

Clinical Pharmacokinetics of IPX066: Evaluation of Dose Proportionality and Effect of Food in Healthy Volunteers.

A critical review of gastric retentive controlled drug delivery.

P2888

s40263-016-0386-8

P304

1079-1095

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40263-016-0386-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Susan H Fox

P577

2016-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27743318

http://www.w3.org/2001/XMLSchema#string

P921

levodopa

Novel Levodopa Formulations for Parkinson's Disease.

about

P2860

P2860

Novel Levodopa Formulations for Parkinson's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921